This Working Group focuses on the economic recovery of businesses and economies from the COVID-19 pandemic. With communities around the world experiencing severe economic impacts, we anticipate a proliferation of efforts to track, assess, explain, and improve economic recovery. We have discussed...

Objectives: To evaluate the cost effectiveness from a UK health and social services perspective of antiplatelet therapies tested in the Second European Stroke Prevention Study (ESPS-2) in preventing recurrent stroke. To demonstrate the value of modelling studies in this area. Design and setting:...

Patients with HCV infection indicate a willingness to accept an increased risk of side effects for sufficient improvement in the likelihood of treatment response. </AbstractSection> Copyright Springer International Publishing AG 2012

Background: A variety of institutional and technological factors have led to reduced lengths of stay (LOS) among patients hospitalized for acute myocardial infarction (MI) over the past two decades, but large international variations in LOS remain. One factor influencing LOS variation may be the...

For many treatments, a patient’s prognosis may be refined by conducting a mid-therapy assessment (MTA). When therapy lasts some time, an MTA predicts a patient’s ultimate outcome based on early signs of response. The availability and timing of such assessments also serve as a mechanism by...

The utility was higher for the PFS state than baseline, but decreased below baseline in non-response and disease progression states. AEs had an impact on utility within the PFS response state. The severe infection AE had a greater impact on utilities for the responding to treatment state...

Background: Abacavir sulfate (abacavir) is associated with a hypersensitivity reaction (HSR) that affects 5-8% of patients. While serious complications are rare, failure to identify it, or abacavir re-challenge following HSR, can be fatal. Genetic screening for HLA-B*5701 can identify patients...